GEODE CAPITAL MANAGEMENT, LLC - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 28 filers reported holding CARDIOME PHARMA CORP in Q2 2017. The put-call ratio across all filers is 6.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q3 2017$40,000
-27.3%
18,731
+53.1%
0.00%
Q2 2017$55,000
+34.1%
12,238
-10.8%
0.00%
Q1 2017$41,000
+13.9%
13,726
+4.1%
0.00%
Q4 2016$36,000
-10.0%
13,180
+2.8%
0.00%
Q3 2016$40,000
-38.5%
12,816
+0.7%
0.00%
Q2 2016$65,000
+25.0%
12,7250.0%0.00%
Q1 2016$52,000
-49.5%
12,725
-0.7%
0.00%
Q4 2015$103,00012,8160.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,195,692$4,953,0002.97%
Tamarack Advisers, LP 1,875,000$2,906,0001.59%
CLOUGH CAPITAL PARTNERS L P 2,667,585$4,135,0000.34%
Rock Springs Capital Management LP 1,200,000$1,860,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,678,364$7,251,0000.06%
KNOTT DAVID M 67,978$105,0000.04%
PUTNAM INVESTMENTS LLC 6,184,266$9,586,0000.01%
AlphaOne Investment Services, LLC 10,625$16,0000.01%
A.R.T. Advisors, LLC 34,872$54,0000.00%
Virtu Financial LLC 11,693$18,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders